$5 million grant to fund saliva tests for students, teachers, staff in schools operated by Special School District of St. Louis County
Antidepressant drug repurposed for patients with coronavirus infection
As more states enact laws legalizing pot, addiction problems may increase
Multi-university study shows app can help students reduce symptoms, ease depression
Such delays lead to serious disparities in access to developmental therapy
In 2019, the FDA approved Spravato for patients with major depressive disorder who hadn’t responded to other treatments. Now, the agency is adding patients who are having suicidal thoughts or have recently attempted to harm themselves or take their own lives.
Grant from National Institute on Drug Abuse to extend landmark study
Low levels of neuropeptide in babies’ cerebrospinal fluid linked to later diagnosis.
Researchers at Washington University School of Medicine are recruiting COVID-19 patients for a clinical trial that will examine whether an existing anti-depressant can be an effective treatment for COVID-19.
Eric Lenze, MD, and Caline Mattar, MD, have launched a study into whether a long-used antidepressant can reduce the likelihood that COVID-19 will turn deadly.